Zacks Investment Research on MSN1d
LLY/INCY Olumiant Shows Superior Efficacy in Pediatric Alopecia StudyEli Lilly LLY and partner Incyte INCY announced that a late-stage study evaluating oral baricitinib in adolescent patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback